Bleeding rate in nasal candidate patients.
Conditions
Interventions
Intervention 1: Combined injection of dexmethomadine (Made by Arang drug therapy Pharmaceutical Company) and ternaxamic acid (Made by Caspian Pharmaceutical Company) in the prevention of bleeding in p
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient is a candidate for nasal surgery The patient must be at least 18 years old The patient has informed consent
Exclusion criteria
Exclusion criteria: The patient has a history of heart disease The patient has a history of seizures The patient has a history of hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgery bleeding. Timepoint: Bleeding measurement time: before drug injection, after drug injection every 15 minutes until the end of surgery. Method of measurement: Volume of blood suctioned in cubic centimeters.;Surgeon satisfaction. Timepoint: before drug injection, after drug injection every 15 minutes until the end of surgery. Method of measurement: The surgeon's satisfaction is evaluated based on a four-point classification. | — |
Secondary
| Measure | Time frame |
|---|---|
| The patient's blood pressure. Timepoint: Every 15 minutes after drug injection until the end of surgery. Method of measurement: sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehroz Karkhanei
Hamedan University of Medical Sciences
Outcome results
None listed